That edge is the main reason why no U.S. soldier has been killed by hostile aircraft since the Korean War, and no U.S. pilot has been downed by an enemy plane since the Vietnam War.
With a study released this morning, Vertex Pharmaceuticals cemented a key advantage in what is expected to be a booming new market for hepatitis C drugs this morning, increasing its edge over Merck, its main competitor.